|
N4BP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.99360577730113E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.55191440096314E-14 |
| Normal-vs-Stage2 |
3.56381590904675E-14 |
| Normal-vs-Stage3 |
1.11022302462516E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.223000E-01 |
| Stage1-vs-Stage3 |
8.305600E-02 |
| Stage1-vs-Stage4 |
1.409630E-04 |
| Stage2-vs-Stage3 |
6.417600E-01 |
| Stage2-vs-Stage4 |
5.885900E-02 |
| Stage3-vs-Stage4 |
7.068000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63435931455069E-12 |
| Normal-vs-AfricanAmerican |
8.26360091465972E-11 |
| Normal-vs-Asian |
1.63147273468667E-12 |
| Caucasian-vs-AfricanAmerican |
7.218800E-01 |
| Caucasian-vs-Asian |
4.551400E-01 |
| AfricanAmerican-vs-Asian |
3.962600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62581059726108E-12 |
| Normal-vs-Female |
1.67643676718399E-14 |
| Male-vs-Female |
1.722170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.96109836439973E-14 |
| Normal-vs-Age(41-60Yrs) |
3.88578058618805E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
3.247700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.585820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.295900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.595200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.369800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.110000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.096400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.584500E-04 |
| Classical-VS-Follicular |
3.305800E-01 |
| Classical-VS-Other |
2.360800E-01 |
| Classical-VS-Normal |
1.75437442351267E-12 |
| Tall-VS-Follicular |
2.708100E-02 |
| Tall-VS-Other |
8.145200E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
4.717000E-01 |
| Follicular-VS-Normal |
1.66788804989437E-12 |
| Other-VS-Normal |
6.02339999999923E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63480340376054E-12 |
| Normal-vs-N1 |
2.22044604925031E-15 |
| N0-vs-N1 |
2.535000E-01 |
|
|
